ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the second quarter of 2012 as follows: Achieved quarterly revenues of $45.2 million, a 4 percent increase over the second quarter of 2011.
